Aug 10 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- FY STATUTORY TOTAL REVENUE FROM ORDINARY ACTIVITIES UP 54.0% TO A$995.6 MILLION
- FY STATUTORY PROFIT ATTRIBUTABLE UP 195.2% TO A$178.2M
- FY2022 FINAL DIVIDEND 41.00 AU CENTSPER SHARE
News: ACL Australian Clinical Labs Posts FY Statutory Total Revenue From Ordinary Activities...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.82 |
Change
-0.010(0.35%) |
Mkt cap ! $555.7M | |||
| Open | High | Low | Value | Volume |
| $2.85 | $2.86 | $2.82 | $382.1K | 134.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 39104 | $2.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 7761 | 37 |
View Market Depth
| Last trade - 13.14pm 28/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |